Cancer Vaccines: Challenges and Opportunities in Translation | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Adrian Bot
B01=Mihail Obrocea
Category1=Non-Fiction
Category=MJCL
Category=MJCM
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€20 to €50
PS=Active
softlaunch

Cancer Vaccines: Challenges and Opportunities in Translation

★★★★★
★★★★★

English

Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist.

Cancer Vaccines: Challenges and Opportunities in Translation:



  • Critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential


  • Discusses theranostics as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy


  • Presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer


  • Reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them
See more
€26.13
€27.50
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Adrian BotB01=Mihail ObroceaCategory1=Non-FictionCategory=MJCLCategory=MJCMCOP=United KingdomDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€20 to €50PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 710g
  • Dimensions: 152 x 229mm
  • Publication Date: 18 Oct 2019
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9780367387556

About

ADRIAN BOT is Senior Director of Scientific Management and Acting Head of Translational Medicine at MannKind Corporation in Valencia California. He obtained his M.D. at the University of Medicine and Pharmacy in Timisoara Romania and his Ph.D. in Biomedical Sciences at Mount Sinai School of Medicine in New York. He previously held appointments at the Scripps Research Institute and Alliance Pharmaceutical Corporation in San Diego. Dr. Bot authored more than one hundred publications and patents in oncology vaccines drug delivery technologies and immunotherapy. He is the Editor-in-Chief of the International Reviews of Immunology and has been on advisory boards of several organizations.MIHAIL OBROCEA is Vice President Clinical Development MannKind Corporation Paramus New Jersey. Dr. Obrocea received his M.D. from the Faculty of Medicine and Pharmacy Bucharest Romania. He is a medical oncologist with over 10 years of academic and industry experience in oncology clinical trials including biologic agents small molecules and cytotoxic agents. Dr. Obrocea has published in oncology peer-reviewed literature and has various patents in the field of biotechnology.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept